SEC Form 4 · accession 0001493152-18-002415
Motus GI Holdings, Inc. · MOTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ascent Biomedical Ventures II, L.P.
10% Owner
Period of report
Feb 16, 2018
Accepted (ET)
Feb 21, 2018 · 6:05 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001686850
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Feb 16, 2018 | C | 144,352 | $0.00 | A | 1,591,481 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF1 | $0.00 | Feb 16, 2018 | C | 144,352 | D | — | — | Common Stock | 144,352 | 0 | D |
| Warrant (right to buy) | $5.00 | Feb 16, 2018 | J | 159,149 | A | Aug 15, 2018 | Feb 16, 2023 | Common Stock | 159,149 | 159,149 | D |
Explanation of responses
- F1Each share of Series A Convertible Preferred Stock is immediately convertible, at the option of the Reporting Person, into one share of common stock, par value $0.0001 per share (the "Common Stock"), of Motus GI Holdings, Inc. ("Motus"), and shall convert into Common Stock upon the occurrence of certain events. Please see the Motus Registration Statement filed with the Securities and Exchange Commission on Form S-1 (File No. 333-222441) (the "Registration Statement") for a complete description of the conversion rights.
- F2The securities were acquired as consideration for entering into one or more agreements in connection with Company's initial public offering. Please see the Registration Statement for a complete description of the warrant terms and such agreements.